Newsletter | March 24, 2026

03.24.26 -- 5 Takeaways From The Boston Open Science & Innovation Forum

SPONSOR

Join this live discussion designed for scientists and leaders seeking to understand where open-source AI is delivering real impact today—and why AI is no longer optional for staying competitive in drug discovery. Registration is free, more info here.

FROM THE EDITOR

5 Takeaways From The Boston Open Science & Innovation Forum

The recent Boston Open Science & Innovation Forum was co-hosted by the Open Molecular Software Foundation (OMSF) and Ginkgo Datapoints.

FEATURED EDITORIAL

Targeting Underlying Biology: Novel Combination Therapies For Chronic Disease

Combination therapies that incorporate cannabinoids and psychedelics signal an important shift in how complex chronic diseases are being approached. 

From Cyclization To The Clinic: The Rising Era Of Cyclic Peptide Therapeutics

The pharmaceutical industry is currently experiencing a golden era for cyclic peptide therapeutics.

INDUSTRY INSIGHTS

Flow Chemistry For Contemporary Isotope Labeling

Gain insight into how late‑stage exchange and flow‑based methods enable efficient access to labeled molecules for pharmaceuticals, mechanistic studies, and analytical applications.

Improving Gene Therapy Development With Organ-On-A-Chip Technology

Explore the current challenges of developing gene therapies, the potential of Organ-on-a-Chip technology, the future of gene therapy, and more.

Compound Library Consortium

See how a novel approach to enhancing drug discovery efforts can significantly improve the chances of identifying promising drug candidates, ultimately accelerating the path from discovery to development.

How To Become A PCR Pro

Discover how PCR works, what impacts reaction success, and how to troubleshoot common challenges with expert guidance and real lab examples designed to help you strengthen your PCR skills.

Particle Engineering For Inhalation Drug Delivery

Review key parameters for choosing the right particle engineering approach to meet dry powder inhaler (DPI) target product profiles for inhalation-based drug products.

SOLUTIONS

PBPK Predictive Modeling Services